Leadership
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
REMAP-COVID
About REMAP-COVID
News
Join Us
Contact
DONATE
< Back to News
Henry Ford Cancer Institute is First in the World to Activate Two New Treatments in GBM AGILE Trial for Glioblastoma
FEBRUARY 3, 2021 | NEWSWISE
https://www.newswise.com/articles/henry-ford-cancer-institute-is-first-in-the-world-to-activate-two-new-treatments-in-gbm-agile-trial-for-glioblastoma?ta=home
Home
Leadership
About REMAP-COVID
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE